Leaflet MAASOL 1.75mg/FLACON kit for radiopharmaceutical preparations for injectable suspension
Indicated for: diagnostic imaging
Route of administration: injectable
Substance: macroaggregates of human albumin (contrast agent)
ATC: V09EB01 (Various | Respiratory system | Technetium (99mtc), particles for injection)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Macroaggregates of human albumin are used in medical imaging, particularly in lung scintigraphy, to assess pulmonary perfusion. These are composed of human albumin particles labeled with a radioactive marker.
The medication is administered intravenously and allows visualization of blood flow in the lungs using nuclear imaging techniques. It is commonly used for diagnosing pulmonary embolism or other lung conditions.
Adverse effects are rare but may include allergic reactions, nausea, or dizziness. Administration must be performed under the supervision of a nuclear medicine specialist.
Macroaggregates of human albumin are not recommended for patients with hypersensitivity to albumin or other components of the medication, as well as those with severe pulmonary hypertension.
General data about MAASOL 1.75mg/FLACON
- Substance: macroaggregates of human albumin
- Date of latest medicines list: 01-11-2021
- Product code: W58782001
- Concentration: 1.75mg / vial
- Pharmaceutical form: kit for radiopharmaceutical preparations for injectable suspension
- Quantity: 5
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.